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DOI 10.1186/s12871-015-0124-7RESEARCH ARTICLE Open AccessDexmedetomidine decreases the emergence
agitation in infant patients undergoing cleft
palate repair surgery after general anesthesia
Wei Peng and TieJun Zhang*Abstract
Background: To determine whether continuous intravenous infusion of dexmedetomidine (DEX) can affect the
incidence of Emergence Agitation (EA) after general anesthesia in infant undergoing cleft palate repair surgery.
Methods: Forty infants underwent cleft palate repair surgery under general anesthesia were randomly divided into
the DEX (D) group and Placebo (P) groups. Patients in group D received continuous intravenous infusion of DEX
0.8 μg · kg-1 · min-1 after the induction. Patients in group P were administered with continuous intravenous infusion
of the equivalent volume of normal saline. Both groups were induced with fentanyl 0.005 mg/Kg, propofol 2 mg/Kg
and cisatracurium 0.2 mg/Kg. Anaesthesia was maintained with continuous intravenous infusion of propofol (2 mg/Kg · h),
remifentanil (0.1 μg/Kg · h), and inhalation of 1 to 3 % sevoflurane.
Result: The heart rate (HR) in group P was significant higher than that in group D at the time of operation (P < 0.05),
postoperative 15 min, 30 min and the time of extubation (P < 0.01). The mean arterial pressure (MAP) in group P was
higher comparing with MAP in group D at the time of extubation (P < 0.05). The spontaneous eye opening times and
spontaneous arm or leg motion times were longer in group D (P < 0.05). The mean agitation scores of patients in group
D were significantly lower than that in group P (P < 0.01). However, the incidence of EA in group P and group D was
90 % and 15 % (P <0.05).
Conclusion: The continuous intravenous infusion of DEX after induction could significantly reduce the occurrence of EA.
Trial registration: The Chinese Clinical Trial Register ChiCTR-TRC-13003865
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Cleft lip and palate as the most common craniofacial
abnormalities in paediatric pathology had an incidence
in 1.8 % in China [1]. Cleft palate repair is one of
the most common oral and maxillofacial sugery in
children and it may be associated with significant post-
operative pain. A minority of infants aged < 3 years could
tolerate the surgery without general anesthesia. However,
anesthetic management during the cleft palate surgical re-
pair always has a high rate (13 %) of postoperative compli-
cations including postoperative swelling of the tongue,
bleeding which maybe because the surgical procedure and
the complications also included pain, nausea and* Correspondence: tiejunzhang23@yeah.net
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(http://creativecommons.org/publicdomain/zevomiting, wound dehiscence, bronchospasm, emergence
agitation or delirium, which may be ascribed to the choice
of anesthesia [2, 3]. Emergence agitation (EA) combined
with vigorous crying may lead to wound dehiscence and
pulmonary complications that might result in delayed
recovery and a prolonged hospital stay. Much effort has
been made to avoid these complications, and to improve
the quality of anesthesia, however, there is no consensus
on the safest anesthetic agents for pediatric patients
undergoing surgical repair of cleft palate.
The typical anesthesia method of infant is inhalational
anesthetic. Sevoflurane, as a popular inhalational anesthetic
for children, has been routinely used because it is less
pungent and has a more rapid onset and offset because of
lower solubility in blood, fast recovery properity, relative
lack of airway irritation and greater hemodynamic stabilityrticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Five point scale
Scoring system for emergence agitation (behavior score)
Sleeping 1
Awake and calm 2
Irritable and crying 3
Inconsolable crying 4
Severe restlessness and disorientation 5
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studies had showed that sevoflurane had a relatively high
incidence of EA in infants [6, 7] even in the absence of any
surgical intervention [8]. EA in pediatric patients is a
clinical entity generally defined by behaviors including
combativeness, excitation, disorientation and inconso-
lability [9]. The incidence of EA is widely ranging in the
literature from 10–80 % and it is usually a self-limited
phenomenon, but can be severe and present dangers to
both patients and caregivers [9]. EA has a phenomenon of
nonpurposeful restlessness and agitation, thrashing, crying
or moaning, disorientation, and incoherence [9], which
frequently happened when children recovering from
anesthesia and can create a challenging situation to their
health care providers.
DEX is a highly specific, potent and selective α2-
adrenoceptor agonist, which has sedative, anxiolytic and
analgesic properties. It has a α2/α1 selectivity ratio of
1600:1, which is eight times more effective compared
with clonidine [10]. DEX has been used effectively in in-
tensive care to aid weaning from mechanical ventilation
[11] and now is being utilized increasingly in infant
anaesthetic [12–14]. It was reported that DEX can
eliminate pain as a potential source of discomfort and
agitation [15, 16].
In this study, we aimed to explore whether the
prophylactic use of DEX could reduce the incidence of
EA in infants undergoing cleft palate repair and confirm
the edative, anxiolytic and analgesic effects of DEX in
clinical treatment of cleft lip and palate.
Methods
The study was approved by the institutional ethics
committee of the School and Hospital of Stomatology
of Wuhan University (Protocol 2013–46, Date: March 1,
2013) and registered with the Chinese Clinical Trial
Register (ChiCTR -TRC-13003865).
Patients and study design
This clinical trial was reviewed and approved by the Ethics
Committee of the School and Hospital of Stomatology of
Wuhan University. This study was conducted at School
and Hospital of Stomatology of Wuhan University in
accordance with the declaration of Helsinki. The written
informed consent was obtained from parents of each in-
fant patient in our study. This study enrolled 40 American
Society of Anesthesiologists (ASA) physical status I
patients aged from 3 months to 24 months scheduled to
undergo cleft palate repair. Exclusion criteria included
bradycardia, influenza, coagulopathy or major systemic
illness. All operations were performed by the same experi-
enced surgeon. The enrolled patients were randomly
divided into group D (continuous infusion 0.8 μg · kg-1 ·
min-1 dexmedetomidine) and group P (continuousinfusion the same as the volume of IV normal saline) sing
a computer-generated sequence of numbers and a sealed
envelope assignment which were prepared and kept by a
research coordinator.Surgical procedure and clinical observations
Vital signs were monitored and recorded throughout the
study. Standard monitoring included electrocardiograph
(ECG), blood pressure and peripheral oxygen saturation.
Basal anaesthesia was administrated by the inhalation of
8 % sevoflurane in 100 % oxygen via a face mask with spon-
taneous ventilation. Patients in group D and group P were
induced with fentanyl 0.005 mg/Kg, propofol 2 mg/Kg and
cisatracurium 0.2 mg/Kg. Anaesthesia was maintained with
continuous infusion of propofol (2 mg · kg-1 · h-1), remifen-
tanil (0.1 μg · kg-1 · h-1) and inhalation of 1 to 3 % sevo-
flurane. Before the end of surgery, analgesia pump was
connected. Analgesia formula: total fentanyl 20 μg · kg-1
was diluted to 100 ml 0.9 % saline with 0.4 μg · kg-1 · h-1
constant rate infusion.
Oral endotracheal intubation of appropriate size for the
age and weight of the child were placed after the induction.
Patients in group P and group D respectively received
continuous intravenous infusion of saline and dexme-
detomidine 0.8 μg · kg-1 · min-1 after the induction. At
the end of surgery, the fresh gas flow was increased to
6 L · min-1, and the effect of the paralytic agent, cisatracur-
ium, was reversed by neostigmine (0.04 mg/Kg). Atropine
(0.01 mg/Kg) was co-administrated with neostigmine. The
trachea was extubated on resumption of spontaneus respi-
ration and control of airway. All the patients received pain
relief.
The heart rate (HR), mean arterial pressure (MAP),
and SpO2 were recorded every 5 min from the time
of induction in operation room. EA was assessed with
5-point scale (Table 1) [17] and scoring system for
emergence agitation (behavior score): sleeping, 1 score;
awake and calm, 2 score; irritable and crying, 3 score;
inconsolable crying, 4 score; severe restlessness and
disorientation, 5 score. EA was recorded every 5 min from
the time of discontinuation of the anaesthetic until the
patients were awake, alert, calm, and responsive to the
parents. Anesthesia and procedure times and per opera-
tive and postoperative side effects were recorded.
Table 2 Demographic and anesthesia data
Group D (n = 20) Group P (n = 20)
Age (years) 12.5 ± 3.8 11.3 ± 4.5
Gender (M/F) 13/7 14/6
Weight (Kg) 9.6 ± 1.9 9.1 ± 1.6
ASA (I/II) 15/5 16/4
During of operation (min) 70.6 ± 32.2 74.8 ± 33.2
During of anesthesia (min) 102.9 ± 34.0 116.8 ± 30.4
Values are mean ± SD or numbers. Differences not significant
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Before initiating the study, a power analysis suggested
that a sample size of 20 patients in each group should be
adequate to detect a 30 % reduction in extubation time
and agitation score with a power of 0.8 and α of 0.05.
The results were expressed as [mean ± SD, n (%)].
Student's t test was used in the comparisons of age,
weight, operating, anesthesia, emergence agitation
score, and recovery time. The gender, ASA and postopera-
tive side effects in two groups were compared using
chi-square and Fisher's exact test. Bonferroni adjustment
was used in the comparisons of intragroup values of MAP,
HR, and SpO2.
Results
A total number of forty infant patients were enrolled in
this study (20 in Group D and 20 in Group P). All the
patients participated in the study were followed up for
the observational period and the flow chart of this study
was shown in Fig. 1. There were no significant differences
in gender, age, body weight, ASA, during of operation and
during of anesthesia between two groups (Table 2).
Comparing with group D, the HR was higher in group
P during the time of operation (P = 0.014), postoperative
15 min (P = 0.003), postoperative 30 min (P = 0.0004)Fig. 1 Consort flow diagramand extubation (P = 0.0001) (Fig. 2). The MAP in
group P was higher than that of group D at extuba-
tion (P = 0.027). The SpO2 data were similar between
two groups (Fig. 3). Intravenous injection with 0.25 mg/kg
Methoxamine Hydrochloride and 0.03 mg/kg Atropine
were performed to tackle the hypotension and bradycar-
dia, respectively.
The respiratory recovery time and remove extubation
time were similar in the two groups. The spontaneous
eye opening time and spontaneous arm or leg motion
time was shorter in the group P than that in the group
D (P = 0.027 and P < 0.0001). There was no significant
difference in the time of discharge to the PACU between
two groups (Table 3).
Fig. 2 Heart rate between the two groups. Values are expressed as mean ± SD (min). *P < 0.05 and & P < 0.01 for group D vs P
Peng and Zhang BMC Anesthesiology  (2015) 15:145 Page 4 of 7The mean agitation scores in the dexmedetomidine
group were significantly lower than the P group at PO
0 min, 10 mim, 20 min, 30 min and 40 min & (P < 0.0001)
(Table 3) (Fig. 4).Discussion
Cleft lip and palate is the most common congenital
facial malformation in humans. It occurs with ethnic
and geographic variation [17]. This disorder is generally
divided into two groups: clefts involving the lip with or
without cleft palate and isolated cleft palate [2]. Cleft lip
and palate can also be part of a syndrome when it is
associated with other congenital defects.
Many factors can contribute to the high rate of EA after
sevoflurane anesthesia in infant patients undergoing cleftFig. 3 MAP between the two groups. Values are expressed as mean ± SD (palate repair surgery and these factors included surgical
procedure, skill of anesthesia management, separating
from the family, incapacity and loss of independence. Cleft
palate repair surgery has specific complications associated
with the surgical procedure [2], such as postoperative
laryngeal edema, Specific complications such as postoper-
ative laryngeal edema may associated with the surgical
procedure which occurred during the cleft palate repair
surgery and it can result in impeded breathing and block-
ing of breathing system. In addition, the repair of cleft
palate leads to significant pain in the postoperative period.
Inadequate pain relief may be the cause of agitation,
particularly after short surgical procedures for which peak
effects of analgesics may be delayed until the child is
completely awake [18]. Since postoperative pain is consid-
ered to be one of the major causes of EA, therefore, it ismin). *P < 0.05 for group D vs P
Table 3 Recovery parameters and the incidence of agitation
was 90 % in group P and 15 % in group D
Group D (n = 20) Group P (n = 20)
Respire recovery time 4.3 ± 1.6 3.9 ± 1.6
Remove extubation time 7.8 ± 1.5 6.5 ± 1.4
Spontaneous eye opening time 33.2 ± 11.0* 17.8 ± 6.1
Spontaneous arm or leg motion
time
25.6 ± 13.7* 9.1 ± 3.0
Discharge to recovery room 55.1 ± 3.0 54.5 ± 2.8
Bronchospasm 1 3
Nausea-vomiting 1 2
Emergence agitation 3 (15 %) 18* (90 %)
Values are expressed as mean ± SD (min). *P < 0.05 for group D vs P
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decrease the incidence of EA. It has been reported in
several previous studies that regional block, opioids, and
nonsteroidal antiflamatory drugs could decrease the inci-
dence of EA [19–22]. Prophylactic propofol appears to be
effective for reducing the incidence and severity of EA in
children emerging from general anesthesia [23]. Transi-
tion to propofol at the end of sevoflurane anesthesia
reduces the incidence of EA and improves the quality of
emergence. There is a small increase in recovery time, but
no delay in discharge home [24].
Although pain may be the cause of postoperative
agitation after general anesthesia, however, there were
still other factors which may induce the occurrence of
EA [25]. And some studies suggest that EA can be pro-
voked without pain. It had been reported in the study of
Isik et al. [26] that the incidence rate of EA was 48 % in
pediatric patients under sevoflurane anesthesia when
undergoing magnetic resonance imaging. In our study,Fig. 4 Agitation scores [mean (SD)]. Values are expressed as mean ± SD (mpatients in both groups received similar pain relief,
however, there was a higher incidence of EA in group
P comparing with patients in group D.
Sevoflurane is related to the high incidence of EA, and
there is a common agreement amongst anesthetists that
sevoflurane can increase the incidence of EA in the post-
operative stage in pediatric patients compared to propo-
fol or halothane. Meta-analysis demonstrated that EA
happened more frequently in children under sevoflurane
anesthesia than propofol anesthesia [27]. Kuratani and
Oi [28] showed that there was a high rate of EA in
pediatric patients with sevoflurane anesthesia compared
with patients with halothane. A higher incidence of EA
was also recorded in patients who received sevoflurane
for nopainful interventions, such as eye examinations
[29]. The reasons for a higher incidence of EA after
sevoflurane were not fully understood. Using the electro-
encephalography during sevoflurane anesthesia, it has
been found that epileptiform seizure activity was ob-
served in non-epileptic patients and sevoflurane was
believed to have a specific side effect on the central
nervous system [30, 31].
DEX, a selective α-2 adrenoceptor agonist with seda-
tive, analgesic, and anxiolytic propery without significant
resporatory depression at clinical dosages, has been
widely used in pediatric and adult populations [32–35].
Guler reported that DEX given 5 min before the end of
surgery, was effective in reducing EA with prolongation
of extubation and emergence times in children undergoing
adenotonsillectomy [36]. Ibacache et al. reported that chil-
dren undergoing lower abdominal and genital surgery from
1 to 10 years anesthetized 1–3 % sevoflurane in 50–50 %
O2/N2O and a single i.v. dose of DEX after induction,
resulted in a reduction of postoperative agitation fromin) & P < 0.0001 for group D vs P
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0.3 μg · Kg-1, respectively. The results of this study
indicated that continuous intravenous infusion of
DEX 0.8 μg · kg-1 · min-1, after anesthesia induction,
reduced the incidence of emergence agitation following
sevoflurane anesthesia in infant patients undergoing cleft
palate repair surgery.
In our studies, all infants were pre-induced with 8 %
sevoflurane until the venous access was established.
Anaesthesia was maintained with a continuous infusion
of propofol (2 mg/Kg · h), remifentanil (0.1 μg/Kg · h),
and inhalation of 1 to 3 % sevoflurane. Patients in group
D received continuous intravenous infusion of DEX
(0.8 μg · kg−1 · min−1). The HR of patients in group D
was lower than group P after induction, however, it was
still within a safe range. Besides, the lower HR could
decrease the myocardial oxygen consumption. MAP in
Group D was more stable than group P. The increasing
HR and MAP of patients in group P in the extubation
period may due to the reason of higher severe level of
agitation and an decrease of HR and MAP of patients in
group D during the extubation period may be attributed
to the effect that dexmedetomidine reduces plasma
norepinephrine levels [37].
We observed 90 % agitation in group P and 15 % in
group D underwent cleft palate repair surgery under
general anesthesia. The higher incidence of EA found in
placebo group compared with the studies of Guler et al.
and Ibacache et al., may be attributed to the cleft palate
repair. Comparing with the results in the study of Guler
et al. and Ibacache et al., the lower incidence of EA in
group D may due to the higher dose of dexmedetodine.
In our study, we found the fact that the infants adminis-
tered dexmedetomidine could slightly prolong respire re-
covery time and remove extubation time. The spontaneous
eye opening times and spontaneous arm or leg motion
times was obviously longer in group D (P < 0.0001), which
showed the sedative effects dexmedetomidine. The time to
discharge to PACU was similar in the two groups.
Sandner-Kıeslıng et al. [38] concluded that nausea
and vomiting was seen in 30 % following sevoflurane
anesthesia for magnetic resonance imaging. Two cases
of nausea and three cases of bronchospasm were ob-
served as side effects in group P, while one case of
nausea and two cases of bronchospasm were observed
as side effects in group D.
As a result, continuous infusion of 0.8 μg · kg-1 · min-1
DEX after induction could significantly decrease the oc-
currence of emergence agitation in infants undergoing
cleft palate repair with sevoflurane anesthesia. The
continuous infusion of DEX in this dose was safe and it
could lead to a decrease incidence of side effects. The
limitation of the current study was the samples size of
the surgery cases of this research.Conclusions
We concluded that continuous intravenous infusion of
DEX 0.8 μg · kg-1 · min-1 after induction significantly
decreases the occurrence of EA in infants undergoing
cleft palate repair under general anesthesia, which may
be helpful for the further treatment.
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